Mismatch negativity is abnormal but not lateralizing in temporal lobe epilepsy

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Lili Zhao, Dongmei An, Limei Mao, Xiangdong Tang, Li He, Dong Zhou
We investigated the changes of mismatch negativity (MMN) in patients with temporal lobe epilepsy (TLE) and explored the possible role of MMN in lateralizing their seizure focus. Thirty patients with TLE and thirty healthy controls were included. MMN ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Alison L. Althaus, Hilary S. McCarren, Aymen Alqazzaz, Cecelia Jackson, John H. McDonough, Carl D. Smith, Ethan Hoffman, Rebecca S. Hammond, Albert J. Robichaud, James J. Doherty
Organophosphorus nerve agents (OPNAs) are irreversible inhibitors of acetylcholinesterase that pose a serious threat to ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Alison L. Althaus, Hilary S. McCarren, Aymen Alqazzaz, Cecelia Jackson, John H. McDonough, Carl D. Smith, Ethan Hoffman, Rebecca S. Hammond, Albert J. Robichaud, James J. Doherty
Organophosphorus nerve agents (OPNAs) are irreversible inhibitors of acetylcholinesterase that pose a serious threat to ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Alison L. Althaus, Hilary S. McCarren, Aymen Alqazzaz, Cecelia Jackson, John H. McDonough, Carl D. Smith, Ethan Hoffman, Rebecca S. Hammond, Albert J. Robichaud, James J. Doherty
Organophosphorus nerve agents (OPNAs) are irreversible inhibitors of acetylcholinesterase that pose a serious threat to ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Alison L. Althaus, Hilary S. McCarren, Aymen Alqazzaz, Cecelia Jackson, John H. McDonough, Carl D. Smith, Ethan Hoffman, Rebecca S. Hammond, Albert J. Robichaud, James J. Doherty
Organophosphorus nerve agents (OPNAs) are irreversible inhibitors of acetylcholinesterase that pose a serious threat to ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Alison L. Althaus, Hilary S. McCarren, Aymen Alqazzaz, Cecelia Jackson, John H. McDonough, Carl D. Smith, Ethan Hoffman, Rebecca S. Hammond, Albert J. Robichaud, James J. Doherty
Organophosphorus nerve agents (OPNAs) are irreversible inhibitors of acetylcholinesterase that pose a serious threat to ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): Alison L. Althaus, Hilary S. McCarren, Aymen Alqazzaz, Cecelia Jackson, John H. McDonough, Carl D. Smith, Ethan Hoffman, Rebecca S. Hammond, Albert J. Robichaud, James J. Doherty
Organophosphorus nerve agents (OPNAs) are irreversible inhibitors of acetylcholinesterase that pose a serious threat to ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

Epilepsy and restless legs syndrome

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): James D. Geyer, Emery E. Geyer, Zachary Fetterman, Paul R. Carney

Objective
Restless legs syndrome (RLS) is a common neurological movement disorder occurring in approximately 10% of the general population. The prevalence of moderately severe RLS is 2.7% overall (3.7% for women and 1.7% for men). Epilepsy is also a common neurological disorder with significant ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

Epilepsy and restless legs syndrome

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): James D. Geyer, Emery E. Geyer, Zachary Fetterman, Paul R. Carney

Objective
Restless legs syndrome (RLS) is a common neurological movement disorder occurring in approximately 10% of the general population. The prevalence of moderately severe RLS is 2.7% overall (3.7% for women and 1.7% for men). Epilepsy is also a common neurological disorder with significant ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

Epilepsy and restless legs syndrome

Publication date: March 2017Source:Epilepsy & Behavior, Volume 68
Author(s): James D. Geyer, Emery E. Geyer, Zachary Fetterman, Paul R. Carney

Objective
Restless legs syndrome (RLS) is a common neurological movement disorder occurring in approximately 10% of the general population. The prevalence of moderately severe RLS is 2.7% overall (3.7% for women and 1.7% for men). Epilepsy is also a common neurological disorder with significant ...

Seguir leyendo →
22
ENE
0

Epilepsy & Behavior

Página 14 de 21 «...101213141516...»